Trial site
CHU de Quebec -Universite Laval Hopital de L'Enfant-Jesus
Québec, G1J 1Z4, CanadaNot linked to an institution yet
- 5running trials
- 1closed trial
The trials here
What the 6 trials at this site are about, from their registry records.
- Phase
- Phase 35 trials
- Phase 1/21 trial
- Status
- Active, not recruiting5 trials
- Completed1 trial
- Lead sponsor
- Janssen Research & Development, LLC4 trials
- Allogene Therapeutics1 trial
- Daiichi Sankyo1 trial
Running trials
Active, not recruiting
A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC
NCT05884398· Phase 3· Janssen Research & Development, LLC· Source
Active, not recruiting
A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC)
NCT05714202· Phase 3· Janssen Research & Development, LLC· Source
Active, not recruiting
Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)
NCT05555732· Phase 3· Daiichi Sankyo· Source
Active, not recruiting
Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell Lymphoma, Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (ALPHA2)
NCT04416984· Phase 1/2· Allogene Therapeutics· Source
Active, not recruiting
A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
NCT03767244· Phase 3· Janssen Research & Development, LLC· Source
Report an error